• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1,4,9,9-四甲基八氢-4,7-(环氧亚甲基)薁-5(1)-酮,一种作为新型冠状病毒潜在抑制剂的天然产物:提取、晶体结构及虚拟筛选方法

1,4,9,9-tetramethyloctahydro-4,7-(epoxymethano)azulen-5(1)-one, a natural product as a potential inhibitor of COVID-19: Extraction, crystal structure, and virtual screening approach.

作者信息

El Bakri Youness, Mohamed Shaaban K, Saravanan Kandasamy, Ahmad Sajjad, Mahmoud Ahmed A, Abdel-Raheem Shaban A A, El-Sayed Wael M, Mague Joel T, Goumri Said Souraya

机构信息

Department of Theoretical and Applied Chemistry, South Ural State University, Chelyabinsk, Russian Federation.

Chemistry and Environmental Division, Manchester Metropolitan University, Manchester M1 5GD, England, United Kingdom.

出版信息

J King Saud Univ Sci. 2023 Jun;35(4):102628. doi: 10.1016/j.jksus.2023.102628. Epub 2023 Mar 4.

DOI:10.1016/j.jksus.2023.102628
PMID:36908997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9984236/
Abstract

In the present work, we describe the extraction of a natural product namely 1,4,9,9-tetramethyloctahydro-4,7-(epoxymethano)azulen-5(1)-one, and its structure was confirmed by single crystal X-ray diffraction analysis. The conformations of the 5-, 6-, and 7-membered rings in the title compound, CHO, have been probed by a Cremer-Pople puckering analysis. C-H···O hydrogen bonds generate chains in the crystal that stretch along the -axis direction. The Hirshfeld surface analysis method was used to stabilize the crystal packing of the natural compound. Accompanied by experimental studies, quantum chemical calculations were also performed to compare the structural elucidation and the results of these geometrical parameters exhibited excellent agreement. The compound was also docked with several drug targets of the SARS-CoV-2 virus and found to show the best binding with the main protease enzyme, having a binding energy of -12.31 kcal/mol and interacting with His41 and Cys145 residues. The dynamic stability deciphered the complex to be stable with an average RMSD of 3.8 Å. The compound dynamics with the enzyme showed the compound conformation to be highly stable. The intermolecular binding free energy determined the compound-main protease enzyme to show high interaction energy of < 40 kcal/mol. Together, these studies demonstrate the compound to be a lead structure against SARS-CoV-2.

摘要

在本工作中,我们描述了一种天然产物即1,4,9,9-四甲基八氢-4,7-(环氧亚甲基)薁-5(1)-酮的提取,并通过单晶X射线衍射分析确定了其结构。通过Cremer-Pople褶皱分析研究了标题化合物CHO中5元、6元和7元环的构象。C-H···O氢键在晶体中形成沿z轴方向延伸的链。采用Hirshfeld表面分析方法来稳定天然化合物的晶体堆积。在实验研究的同时,还进行了量子化学计算,以比较结构解析,这些几何参数的结果显示出极好的一致性。该化合物还与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒的几个药物靶点进行对接,发现与主要蛋白酶具有最佳结合,结合能为-12.31 kcal/mol,并与His41和Cys145残基相互作用。动力学稳定性表明该复合物稳定,平均均方根偏差(RMSD)为3.8 Å。该化合物与酶的动力学表明化合物构象高度稳定。分子间结合自由能确定该化合物与主要蛋白酶显示出小于40 kcal/mol的高相互作用能。总之,这些研究表明该化合物是针对SARS-CoV-2的先导结构。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/145570765d0a/gr10_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/6b4a943c1c1c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/5cd2d359f735/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/657245e7075d/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/36027d7ac2d4/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/da0e70865b98/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/72ae9fe28235/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/56b604471200/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/9d85a7d9a395/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/a4d89b66544d/gr9_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/145570765d0a/gr10_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/6b4a943c1c1c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/5cd2d359f735/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/657245e7075d/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/36027d7ac2d4/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/da0e70865b98/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/72ae9fe28235/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/56b604471200/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/9d85a7d9a395/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/a4d89b66544d/gr9_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f70/9984236/145570765d0a/gr10_lrg.jpg

相似文献

1
1,4,9,9-tetramethyloctahydro-4,7-(epoxymethano)azulen-5(1)-one, a natural product as a potential inhibitor of COVID-19: Extraction, crystal structure, and virtual screening approach.1,4,9,9-四甲基八氢-4,7-(环氧亚甲基)薁-5(1)-酮,一种作为新型冠状病毒潜在抑制剂的天然产物:提取、晶体结构及虚拟筛选方法
J King Saud Univ Sci. 2023 Jun;35(4):102628. doi: 10.1016/j.jksus.2023.102628. Epub 2023 Mar 4.
2
Virtual Screening of Phytochemicals as Potential Inhibitors of SARS-CoV-2 Main Protease Enzyme.基于 SARS-CoV-2 主蛋白酶的虚拟筛选潜在抑制剂的植物化学成分
Molecules. 2022 Nov 21;27(22):8103. doi: 10.3390/molecules27228103.
3
Synthesis, crystal structure, Hirshfeld surface analysis, DFT, molecular docking and molecular dynamic simulation studies of (E)-2,6-bis(4-chlorophenyl)-3-methyl-4-(2-(2,4,6-trichlorophenyl)hydrazono)piperidine derivatives.(E)-2,6-双(4-氯苯基)-3-甲基-4-(2-(2,4,6-三氯苯基)肼基)哌啶衍生物的合成、晶体结构、 Hirshfeld表面分析、密度泛函理论、分子对接和分子动力学模拟研究
J Mol Struct. 2022 Oct 15;1266:133483. doi: 10.1016/j.molstruc.2022.133483. Epub 2022 Jun 8.
4
Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.从天然来源开发针对冠状病毒蛋白酶的有效治疗分子。
Int J Mol Sci. 2021 Aug 30;22(17):9431. doi: 10.3390/ijms22179431.
5
Synthesis, crystal structure, and a molecular modeling approach to identify effective antiviral hydrazide derivative against the main protease of SARS-CoV-2.合成、晶体结构以及一种分子建模方法,用于鉴定针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶的有效抗病毒酰肼衍生物。
J Mol Struct. 2022 Oct 5;1265:133391. doi: 10.1016/j.molstruc.2022.133391. Epub 2022 May 28.
6
Virtual screening of natural products inspired in-house library to discover potential lead molecules against the SARS-CoV-2 main protease.对天然产物内部库进行虚拟筛选,以发现针对新型冠状病毒主要蛋白酶的潜在先导分子。
J Biomol Struct Dyn. 2023 Mar;41(5):2033-2045. doi: 10.1080/07391102.2022.2027271. Epub 2022 Jan 19.
7
A threefold approach including quantum chemical, molecular docking and molecular dynamic studies to explore the natural compounds from Centaurea jacea as the potential inhibitors for COVID-19.采用量子化学、分子对接和分子动力学研究的三重方法,探索矢车菊中的天然化合物作为 COVID-19 的潜在抑制剂。
Braz J Biol. 2021 Sep 3;83:e247604. doi: 10.1590/1519-6984.247604. eCollection 2021.
8
Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2.喹啉衍生物作为抗SARS-CoV-2蛋白酶抑制剂的设计、合成及分子动力学模拟研究
J Biomol Struct Dyn. 2022;40(21):10519-10542. doi: 10.1080/07391102.2021.1946716. Epub 2021 Jul 12.
9
Structure-property relationship in thioxotriaza-spiro derivative: Crystal structure and molecular docking analysis against SARS-CoV-2 main protease.硫代三氮杂螺环衍生物的结构-性质关系:针对SARS-CoV-2主要蛋白酶的晶体结构与分子对接分析
J Mol Struct. 2022 Feb 15;1250:131746. doi: 10.1016/j.molstruc.2021.131746. Epub 2021 Oct 17.
10
Inhibition of multiple SARS-CoV-2 proteins by an antiviral biomolecule, seselin from deciphered using molecular docking analysis.一种抗病毒生物分子 seselin 通过分子对接分析来抑制多种 SARS-CoV-2 蛋白。
J Biomol Struct Dyn. 2022;40(21):11070-11081. doi: 10.1080/07391102.2021.1955009. Epub 2021 Aug 25.

引用本文的文献

1
Metabolomics and microscopic profiling of flaxseed meal- incorporated Peda.添加亚麻籽粕的佩德(一种印度传统乳制品)的代谢组学和微观分析
Food Chem (Oxf). 2024 Aug 22;9:100217. doi: 10.1016/j.fochms.2024.100217. eCollection 2024 Dec 30.
2
New Pyrimidinone Bearing Aminomethylenes and Schiff Bases as Potent Antioxidant, Antibacterial, SARS-CoV-2, and COVID-19 Main Protease M Inhibitors: Design, Synthesis, Bioactivities, and Computational Studies.含氨亚甲基和席夫碱的新型嘧啶酮作为强效抗氧化剂、抗菌剂、SARS-CoV-2和COVID-19主要蛋白酶M抑制剂:设计、合成、生物活性及计算研究
ACS Omega. 2024 Jun 4;9(24):25730-25747. doi: 10.1021/acsomega.3c09393. eCollection 2024 Jun 18.

本文引用的文献

1
Reaction of 7α-bromo-6-nitrocholest-5-enes with hydrazine: Formation of steroidal pyrazolines and molecular docking against SARS-CoV-2 omicron protease.7α-溴-6-硝基胆甾-5-烯与肼的反应:甾体吡唑啉的形成及针对 SARS-CoV-2 奥密克戎蛋白酶的分子对接。
Steroids. 2022 Dec;188:109120. doi: 10.1016/j.steroids.2022.109120. Epub 2022 Oct 5.
2
: a program for Hirshfeld surface analysis, visualization and quantitative analysis of molecular crystals.用于分子晶体的 Hirshfeld 表面分析、可视化和定量分析的程序。
J Appl Crystallogr. 2021 Apr 27;54(Pt 3):1006-1011. doi: 10.1107/S1600576721002910. eCollection 2021 Jun 1.
3
Accurate crystal structures and chemical properties from NoSpherA2.
来自NoSpherA2的精确晶体结构和化学性质。
Chem Sci. 2020 Nov 9;12(5):1675-1692. doi: 10.1039/d0sc05526c.
4
Alchemical Binding Free Energy Calculations in AMBER20: Advances and Best Practices for Drug Discovery.在 AMBER20 中进行的炼金术结合自由能计算:药物发现的进展和最佳实践。
J Chem Inf Model. 2020 Nov 23;60(11):5595-5623. doi: 10.1021/acs.jcim.0c00613. Epub 2020 Sep 16.
5
Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19.达芦那韦/考比司他治疗新型冠状病毒肺炎的抗病毒活性及安全性
Open Forum Infect Dis. 2020 Jun 21;7(7):ofaa241. doi: 10.1093/ofid/ofaa241. eCollection 2020 Jul.
6
Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?甘草酸:治疗 COVID-19 感染及相关呼吸综合征的替代药物?
Pharmacol Ther. 2020 Oct;214:107618. doi: 10.1016/j.pharmthera.2020.107618. Epub 2020 Jun 24.
7
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study.法匹拉韦治疗新型冠状病毒肺炎的实验性治疗:一项开放标签对照研究。
Engineering (Beijing). 2020 Oct;6(10):1192-1198. doi: 10.1016/j.eng.2020.03.007. Epub 2020 Mar 18.
8
COVID-19 pathophysiology: A review.新型冠状病毒肺炎的病理生理学:综述。
Clin Immunol. 2020 Jun;215:108427. doi: 10.1016/j.clim.2020.108427. Epub 2020 Apr 20.
9
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.抗2019冠状病毒病(COVID-19)的氨基喹啉:氯喹或羟氯喹。
Int J Antimicrob Agents. 2020 Apr;55(4):105945. doi: 10.1016/j.ijantimicag.2020.105945. Epub 2020 Mar 17.
10
Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients.新型冠状病毒病 2019(COVID-19):919 例患者影像学表现的系统评价。
AJR Am J Roentgenol. 2020 Jul;215(1):87-93. doi: 10.2214/AJR.20.23034. Epub 2020 Mar 14.